48,851
edits
Difference between revisions of "Cancer antigen 125"
Jump to navigation
Jump to search
→Positive
| Line 9: | Line 9: | ||
*[[Pancreatic ductal adenocarcinoma]].<ref name=pmid27093451>{{Cite journal | last1 = Jiang | first1 = K. | last2 = Tan | first2 = E. | last3 = Sayegh | first3 = Z. | last4 = Centeno | first4 = B. | last5 = Malafa | first5 = M. | last6 = Coppola | first6 = D. | title = Cancer Antigen 125 (CA125, MUC16) Protein Expression in the Diagnosis and Progression of Pancreatic Ductal Adenocarcinoma. | journal = Appl Immunohistochem Mol Morphol | volume = | issue = | pages = | month = Apr | year = 2016 | doi = 10.1097/PAI.0000000000000368 | PMID = 27093451 }}</ref> | *[[Pancreatic ductal adenocarcinoma]].<ref name=pmid27093451>{{Cite journal | last1 = Jiang | first1 = K. | last2 = Tan | first2 = E. | last3 = Sayegh | first3 = Z. | last4 = Centeno | first4 = B. | last5 = Malafa | first5 = M. | last6 = Coppola | first6 = D. | title = Cancer Antigen 125 (CA125, MUC16) Protein Expression in the Diagnosis and Progression of Pancreatic Ductal Adenocarcinoma. | journal = Appl Immunohistochem Mol Morphol | volume = | issue = | pages = | month = Apr | year = 2016 | doi = 10.1097/PAI.0000000000000368 | PMID = 27093451 }}</ref> | ||
*[[Epithelioid sarcoma]] - reported.<ref name=pmid16740043>{{Cite journal | last1 = Lee | first1 = HI. | last2 = Kang | first2 = KH. | last3 = Cho | first3 = YM. | last4 = Lee | first4 = OJ. | last5 = Ro | first5 = JY. | title = Proximal-type epithelioid sarcoma with elevated serum CA 125: report of a case with CA 125 immunoreactivity. | journal = Arch Pathol Lab Med | volume = 130 | issue = 6 | pages = 871-4 | month = Jun | year = 2006 | doi = 10.1043/1543-2165(2006)130[871:PESWES]2.0.CO;2 | PMID = 16740043 }}</ref> | *[[Epithelioid sarcoma]] - reported.<ref name=pmid16740043>{{Cite journal | last1 = Lee | first1 = HI. | last2 = Kang | first2 = KH. | last3 = Cho | first3 = YM. | last4 = Lee | first4 = OJ. | last5 = Ro | first5 = JY. | title = Proximal-type epithelioid sarcoma with elevated serum CA 125: report of a case with CA 125 immunoreactivity. | journal = Arch Pathol Lab Med | volume = 130 | issue = 6 | pages = 871-4 | month = Jun | year = 2006 | doi = 10.1043/1543-2165(2006)130[871:PESWES]2.0.CO;2 | PMID = 16740043 }}</ref> | ||
==Positive or negative== | |||
*[[Cholangiocarcinoma]] +ve/-ve (30 +ve of 63 cases<ref name=pmid22286058>{{Cite journal | last1 = Higashi | first1 = M. | last2 = Yamada | first2 = N. | last3 = Yokoyama | first3 = S. | last4 = Kitamoto | first4 = S. | last5 = Tabata | first5 = K. | last6 = Koriyama | first6 = C. | last7 = Batra | first7 = SK. | last8 = Yonezawa | first8 = S. | title = Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type. | journal = Pathobiology | volume = 79 | issue = 2 | pages = 101-6 | month = | year = 2012 | doi = 10.1159/000335164 | PMID = 22286058 }}</ref>) | |||
==Usually negative== | ==Usually negative== | ||